Ahmedabad, India – December 13, 2023 – Sterling Accuris Diagnostics, a leading chain of NABL-accredited pathology laboratories has announced the acquisition of Ahmedabad based Vaibhav Analytical Services, a leading provider of analytical testing services, including pharmaceutical/drug testing. With this acquisition, Sterling Accuris has successfully expanded its range of services offered to fields such as pharmaceutical analytical testing.
The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. Established in 1999, Vaibhav Analytical Services is a service provider to the pharmaceutical industries and is acclaimed for its expertise in pharmaceutical analysis, a critical aspect of drug development and manufacturing. Vaibhav Analytical Services operates its NABL accredited laboratory, ensuring strict compliance with international standards for pharmaceutical testing at Ahmedabad and services clients from across India. The company has also received approval from the Nigerian Government (NAFDAC) as a CRIA authorised laboratory.
Mr. Rajiv Sharma, MD of Sterling Accuris Diagnostics, emphasized the significance of this acquisition “This strategic move aligns with our commitment to advance healthcare through innovation and excellence in diagnostics and analytical testing services. Analytical testing assists biotech, food, environmental, and pharmaceutical companies that provide products to consumers for safety assurance and quality control, and we want to actively collaborate with them for all their testing needs.
Mr. Ankush Gupta, CEO of Sterling Accuris Diagnostics, highlights, “Vaibhav Analytical’s inclusion positions us to meet the increasing demand for comprehensive pharmaceutical testing, contributing to the highest standards of safety and efficacy.”
Mr. Gaurang Oza, partner of Vaibhav Analytical Services, expressed his enthusiasm, stating, “This collaboration marks a new chapter for Vaibhav Analytical Services. By joining forces with Sterling Accuris, we aim to contribute to advancements in pharmaceutical testing and ensure the highest standards of safety and efficacy.”
